Total Payments
$112,803
2022 Payments
$2,251
Companies
11
Transactions
95
Medicare Patients
774
Medicare Billing
$423,978
Payment Breakdown by Category
Consulting$95,421 (84.6%)
Travel$8,039 (7.1%)
Other$7,220 (6.4%)
Food & Beverage$2,122 (1.9%)
Education$0.83 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $95,421 | 28 | 84.6% |
| Travel and Lodging | $8,039 | 30 | 7.1% |
| Honoraria | $7,220 | 3 | 6.4% |
| Food and Beverage | $2,122 | 33 | 1.9% |
| Education | $0.83 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $42,430 | 25 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $19,177 | 16 | $0 (2020) |
| Acorda Therapeutics, Inc | $17,375 | 18 | $0 (2019) |
| ACADIA Pharmaceuticals Inc | $11,399 | 12 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $8,486 | 2 | $0 (2018) |
| Eisai Inc. | $5,933 | 9 | $0 (2020) |
| Lundbeck LLC | $3,904 | 6 | $0 (2017) |
| Amneal Pharmaceuticals LLC | $2,463 | 4 | $0 (2019) |
| Avion Pharmaceuticals | $1,620 | 1 | $0 (2021) |
| US WorldMeds, LLC | $15.26 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $2,251 | 3 | JAZZ PHARMACEUTICALS INC. ($2,250) |
| 2021 | $16,300 | 7 | JAZZ PHARMACEUTICALS INC. ($14,680) |
| 2020 | $10,183 | 12 | Eisai Inc. ($5,933) |
| 2019 | $39,459 | 21 | JAZZ PHARMACEUTICALS INC. ($14,131) |
| 2018 | $30,023 | 30 | ACADIA Pharmaceuticals Inc ($8,701) |
| 2017 | $14,587 | 22 | Acorda Therapeutics, Inc ($6,585) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/14/2022 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 11/17/2022 | Travere Therapeutics, Inc. | Cholbam (Drug) | Education | In-kind items and services | $0.83 | General |
| Category: Hepatology | ||||||
| 05/10/2022 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 11/16/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 10/07/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| 09/24/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| 06/17/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $3,180.00 | General |
| 06/11/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 06/10/2021 | Avion Pharmaceuticals | Dhivy (Drug) | Honoraria | Cash or cash equivalent | $1,620.00 | General |
| Category: Parkinson's disease | ||||||
| 01/21/2021 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 11/09/2020 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 02/28/2020 | Jazz Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/29/2020 | Eisai Inc. | — | Consulting Fee | Cash or cash equivalent | $4,380.00 | General |
| 01/29/2020 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $1,183.00 | General |
| 01/29/2020 | Jazz Pharmaceuticals Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/29/2020 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $162.63 | General |
| 01/29/2020 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $80.92 | General |
| 01/29/2020 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $39.98 | General |
| 01/29/2020 | Eisai Inc. | — | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| 01/29/2020 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $27.66 | General |
| 01/29/2020 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| 01/29/2020 | Eisai Inc. | — | Food and Beverage | Cash or cash equivalent | $12.05 | General |
| 12/23/2019 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $7,300.00 | General |
| 12/23/2019 | JAZZ PHARMACEUTICALS INC. | — | Travel and Lodging | Cash or cash equivalent | $456.18 | General |
| 12/23/2019 | JAZZ PHARMACEUTICALS INC. | — | Travel and Lodging | Cash or cash equivalent | $421.44 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 166 | 17,003 | $513,246 | $100,411 |
| 2022 | 9 | 199 | 19,774 | $588,211 | $114,697 |
| 2021 | 8 | 217 | 21,548 | $508,188 | $126,621 |
| 2020 | 7 | 192 | 13,237 | $355,327 | $82,249 |
Total Patients
774
Total Services
71,562
Medicare Billing
$423,978
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 23 | 11,245 | $274,112 | $55,835 | 20.4% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 11 | 5,550 | $108,111 | $22,532 | 20.8% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 25 | 68 | $75,353 | $9,223 | 12.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 31 | $16,275 | $3,836 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 42 | $14,070 | $3,484 | 24.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 21 | 21 | $15,435 | $2,931 | 19.0% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2023 | 19 | 46 | $9,890 | $2,570 | 26.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 25 | 12,150 | $296,844 | $59,571 | 20.1% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2022 | 11 | 7,350 | $133,532 | $29,217 | 21.9% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2022 | 22 | 63 | $70,763 | $8,429 | 11.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $21,080 | $3,925 | 18.6% |
| 64612 | Injection of chemical for paralysis of nerve muscles on side of face | Office | 2022 | 12 | 36 | $29,680 | $3,427 | 11.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 36 | $12,060 | $3,324 | 27.6% |
| 95874 | Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | Office | 2022 | 19 | 53 | $11,395 | $3,249 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 23 | $11,385 | $2,831 | 24.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 23 | 32 | $1,472 | $724.59 | 49.2% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 29 | 13,426 | $329,899 | $65,257 | 19.8% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2021 | 14 | 7,850 | $134,796 | $30,154 | 22.4% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 27 | 69 | $13,515 | $9,452 | 69.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 39 | 39 | $8,969 | $6,049 | 67.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 50 | 56 | $7,145 | $5,278 | 73.9% |
| 95874 | Needle measurement and recording of electrical activity of muscles for guidance with injection of chemical for destruction of muscles | Office | 2021 | 22 | 57 | $4,631 | $3,734 | 80.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 26 | $4,636 | $3,395 | 73.2% |
| 64612 | Injection of chemical for destruction of nerve muscles on one side of face | Office | 2021 | 11 | 25 | $4,597 | $3,302 | 71.8% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 30 | 13,000 | $317,400 | $59,705 | 18.8% |
About Dr. Charles Adler, M.D
Dr. Charles Adler, M.D is a Neurology healthcare provider based in Scottsdale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023091022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Adler, M.D has received a total of $112,803 in payments from pharmaceutical and medical device companies, with $2,251 received in 2022. These payments were reported across 95 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($95,421).
As a Medicare-enrolled provider, Adler has provided services to 774 Medicare beneficiaries, totaling 71,562 services with total Medicare billing of $423,978. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Scottsdale, AZ
- Active Since 11/22/2005
- Last Updated 02/13/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1023091022
Products in Payments
- NUPLAZID (Drug) $11,399
- INGREZZA (Drug) $6,501
- SUNOSI (Drug) $4,000
- NORTHERA (Drug) $3,904
- RYTARY (Drug) $2,463
- Dhivy (Drug) $1,620
- MYOBLOC (Biological) $15.26
- Cholbam (Drug) $0.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Scottsdale
Dr. Nida Laurin, M.d, M.D
Neurology — Payments: $1.2M
Neurology $1.2M
Dr. Amaal Starling, M.d, M.D
Neurology — Payments: $314,467
Neurology $314,467
Dr. Dean Wingerchuk, M.d, M.D
Neurology — Payments: $314,438
Neurology $314,438
Dr. Virgilio Evidente, M.d, M.D
Neurology — Payments: $280,162
Neurology $280,162
David Saperstein, Md, MD
Neurology — Payments: $173,854
Neurology $173,854
Dr. Cornelia Drees, M.d, M.D
Neurology — Payments: $171,652
Neurology $171,652